83 related articles for article (PubMed ID: 8390204)
1. Receptor binding and cytotoxicity studies with melanotropin fragments containing melphalan.
Süli-Vargha H; Ghanem G; Morandini R; Libert A; Botyánszki J; Medzihradszky K
Ann N Y Acad Sci; 1993 May; 680():616-8. PubMed ID: 8390204
[No Abstract] [Full Text] [Related]
2. Receptor-mediated cytotoxicity of alpha-MSH fragments containing melphalan in a human melanoma cell line.
Morandini R; Süli-Vargha H; Libert A; Loir B; Botyánszki J; Medzihradszky K; Ghanem G
Int J Cancer; 1994 Jan; 56(1):129-33. PubMed ID: 8262669
[TBL] [Abstract][Full Text] [Related]
3. Receptors for melanocyte-stimulating hormone on melanoma cells.
Eberle AN; Siegrist W; Bagutti C; Chluba-De Tapia J; Solca F; Wikberg JE; Chhajlani V
Ann N Y Acad Sci; 1993 May; 680():320-41. PubMed ID: 8390156
[No Abstract] [Full Text] [Related]
4. Attempts to use alpha-melanotropin-containing melphalan in melanoma patients.
Lejeune FJ; Ghanem GE
Ann N Y Acad Sci; 1993 May; 680():391-400. PubMed ID: 8390159
[No Abstract] [Full Text] [Related]
5. Evidence for the internalization of [125I-Tyr2, Nle4, D-Phe7] alpha-MSH following binding to the MSH receptor of B16 murine melanoma cells.
Adams G; Olivier GW; Branch SK; Moss SH; Notarianni LJ; Pouton CW
Ann N Y Acad Sci; 1993 May; 680():440-1. PubMed ID: 8390163
[No Abstract] [Full Text] [Related]
6. Synthesis and receptor binding analysis of thirteen oligomeric alpha-MSH analogs.
Brandenburger Y; Rose K; Bagutti C; Eberle AN
J Recept Signal Transduct Res; 1999; 19(1-4):467-80. PubMed ID: 10071778
[TBL] [Abstract][Full Text] [Related]
7. A cleavable biotinylated photoactivable derivative of alpha-MSH. Its application to the characterization and isolation of the alpha-MSH receptor.
Ahmed AR; Olivier GW; Branch SK; Moss SH; Notarianni LJ; Pouton CW
Ann N Y Acad Sci; 1993 May; 680():442-4. PubMed ID: 8390164
[No Abstract] [Full Text] [Related]
8. Synthesis of alpha-MSH fragments containing phenylalanine mustard for receptor studies.
Süli-Vargha H; Botyánszki J; Medzihradszky-Schweiger H; Medzihradszky K
Int J Pept Protein Res; 1990 Sep; 36(3):308-15. PubMed ID: 2177734
[TBL] [Abstract][Full Text] [Related]
9. Influence of alpha-MSH terminal amino acids on binding affinity and biological activity in melanoma cells.
Sahm UG; Olivier GW; Branch SK; Moss SH; Pouton CW
Peptides; 1994; 15(3):441-6. PubMed ID: 7937316
[TBL] [Abstract][Full Text] [Related]
10. Human melanoma targeting with alpha-MSH-melphalan conjugate.
Ghanem GE; Libert A; Arnould R; Vercammen A; Lejeune F
Melanoma Res; 1991; 1(2):105-14. PubMed ID: 1668532
[TBL] [Abstract][Full Text] [Related]
11. Interaction of an alpha-melanocyte-stimulating hormone-diphtheria toxin fusion protein with melanotropin receptors in human melanoma metastases.
Tatro JB; Wen Z; Entwistle ML; Atkins MB; Smith TJ; Reichlin S; Murphy JR
Cancer Res; 1992 May; 52(9):2545-8. PubMed ID: 1314697
[TBL] [Abstract][Full Text] [Related]
12. Melanocortin probes for the melanoma MC1 receptor: synthesis, receptor binding and biological activity.
Erskine-Grout ME; Olivier GW; Lucas P; Sahm UG; Branch SK; Moss SH; Notarianni LJ; Pouton CW
Melanoma Res; 1996 Apr; 6(2):89-94. PubMed ID: 8791265
[TBL] [Abstract][Full Text] [Related]
13. [111In]DTPA-labeled analogues of alpha-MSH for the detection of MSH receptors in vitro and in vivo.
Bagutti C; Stolz B; Albert R; Bruns C; Pless J; Eberle AN
Ann N Y Acad Sci; 1993 May; 680():445-7. PubMed ID: 8390165
[No Abstract] [Full Text] [Related]
14. MSH receptors and the response of human A375 melanoma cells to interleukin-1 beta.
Baumann JB; Bagutti C; Siegrist W; Christen E; Zumsteg U; Eberle AN
J Recept Signal Transduct Res; 1997; 17(1-3):199-210. PubMed ID: 9029491
[TBL] [Abstract][Full Text] [Related]
15. Immunoreactive alpha-melanotropin as an autocrine effector in human melanoma cells.
Loir B; Bouchard B; Morandini R; Del Marmol V; Deraemaecker R; Garcia-Borron JC; Ghanem G
Eur J Biochem; 1997 Mar; 244(3):923-30. PubMed ID: 9108267
[TBL] [Abstract][Full Text] [Related]
16. Binding of anti-inflammatory alpha-melanocyte-stimulating-hormone peptides and proinflammatory cytokines to receptors on melanoma cells.
Lyson K; Ceriani G; Takashima A; Catania A; Lipton JM
Neuroimmunomodulation; 1994; 1(2):121-6. PubMed ID: 7489322
[TBL] [Abstract][Full Text] [Related]
17. MSH receptors on mouse and human melanoma cells: receptor identification, analysis and quantification.
Siegrist W; Bagutti C; Solca F; Girard J; Eberle AN
Prog Histochem Cytochem; 1992; 26(1-4):110-8. PubMed ID: 1336609
[No Abstract] [Full Text] [Related]
18. Biologically active monoiodinated alpha-MSH derivatives for receptor binding studies using human melanoma cells.
Eberle AN; Verin VJ; Solca F; Siegrist W; Küenlin C; Bagutti C; Stutz S; Girard J
J Recept Res; 1991; 11(1-4):311-22. PubMed ID: 1653337
[TBL] [Abstract][Full Text] [Related]
19. Prolonged stimulation of S91 melanoma tyrosinase by [Nle4, D-Phe7]-substituted alpha-melanotropins.
Abdel Malek ZA; Kreutzfeld KL; Marwan MM; Hadley ME; Hruby VJ; Wilkes BC
Cancer Res; 1985 Oct; 45(10):4735-40. PubMed ID: 2992767
[TBL] [Abstract][Full Text] [Related]
20. Evidence for alternate points of attachment for alpha-MSH and its stereoisomer [Nle4, D-Phe7]-alpha-MSH at the melanocortin-1 receptor.
Frändberg PA; Muceniece R; Prusis P; Wikberg J; Chhajlani V
Biochem Biophys Res Commun; 1994 Aug; 202(3):1266-71. PubMed ID: 8060302
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
